Page 8 - Evaluate Safety News Today : Breaking News, Live Up

Genmab A/S: Genmab Announces Multiple Abstracts to be Presented at the 64th Annual Meeting and Exposition of the American Society of Hematology (ASH)

Published: November 3, 2022

Nineteen abstracts accepted, including multiple presentations on the safety and efficacy of investigational epcoritamab (DuoBody-CD3xCD20) in a variety of treatment settings and hematologic malignancies

Source: finanznachrichten.de

Omega Therapeutics Receives Orphan Drug Designation for OTX-2002 for the Treatment of Hepatocellular Carcinoma

Published: November 2, 2022

/PRNewswire/ -- Omega Therapeutics, Inc. ("Omega"), a clinical-stage biotechnology company pioneering the first systematic approach to use mRNA therapeutics as...

Source: prnewswire.com

OliX Pharmaceuticals Announces IND Submission to U.S. FDA to Evaluate Safety and Tolerability of OLX10212 in Phase 1 Clinical Trial | DNA RNA and Cells

Published: July 2, 2022

OliX Pharmaceuticals Announces IND Submission to U.S. FDA to Evaluate Safety and Tolerability of OLX10212 in Phase 1 Clinical Trial

Source: pipelinereview.com

Seqirus' Holly Springs Manufacturing Facility Designated By U.S. Government As Pandemic Ready

Published: June 6, 2022

Seqirus, a global leader in influenza prevention and a business of CSL Limited (ASX: CSL), today announced that the company's manufacturing...

Source: pharmaceuticalonline.com

Seqirus' Holly Springs Manufacturing Facility Designated by U.S. Government as Pandemic Ready

Published: June 2, 2022

/PRNewswire/ -- Seqirus, a global leader in influenza prevention and a business of CSL Limited (ASX: CSL), today announced that the company's manufacturing...